These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12792922)

  • 41. Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16.
    Marlton P; Keating M; Kantarjian H; Pierce S; O'Brien S; Freireich EJ; Estey E
    Leukemia; 1995 Jun; 9(6):965-71. PubMed ID: 7596186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Specific chromosomal aberrations in de novo acute myeloid leukemia: a comparative analysis of results with a report of three novel chromosomal rearrangements t(7;14)(q35;q13), t(8;18)(p11.2;q12), t(13;15) in Indian population.
    Ahmad F; Dalvi R; Das BR; Mandava S
    Cancer Detect Prev; 2008; 32(2):168-77. PubMed ID: 18639991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Core binding factor acute myeloid leukaemia and c-KIT mutations.
    Riera L; Marmont F; Toppino D; Frairia C; Sismondi F; Audisio E; Di Bello C; D'Ardia S; Di Celle PF; Messa E; Inghirami G; Vitolo U; Pich A
    Oncol Rep; 2013 May; 29(5):1867-72. PubMed ID: 23467883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Various distinctive cytogenetic abnormalities in patients with acute myeloid leukaemia aged 60 years and older express adverse prognostic value: results from a prospective clinical trial.
    van der Holt B; Breems DA; Berna Beverloo H; van den Berg E; Burnett AK; Sonneveld P; Löwenberg B
    Br J Haematol; 2007 Jan; 136(1):96-105. PubMed ID: 17129222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M; Kusenda J; Babusikova O
    Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?
    Dissing M; Le Beau MM; Pedersen-Bjergaard J
    J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical and laboratory studies on childhood acute leukemia with 11q23 abnormalities].
    He YX; Xue YQ; He J; Zhang XL; Ji ZH; Huang YP; Zhu XM; He HL; Chai YH; Zhu LL
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):358-61. PubMed ID: 12941190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute myeloid leukaemia M0: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients.
    Béné MC; Bernier M; Casasnovas RO; Castoldi G; Doekharan D; van der Holt B; Knapp W; Lemez P; Ludwig WD; Matutes E; Orfao A; Schoch C; Sperling C; van't Veer MB
    Br J Haematol; 2001 Jun; 113(3):737-45. PubMed ID: 11380465
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prognostic significance of cytogenetic changes in patients with acute myeloid leukemia (AML). (Analysis of results in 105 patients treated at the Hemato-oncology Clinic of the University Hospital in Olomouc from 1997 to 2000].
    Jarosová M; Indrák K; Holzerová M; Hubácek J; Faber E; Papajík T; Raida L; Szotkowski T; Knotková R; Hlusí T; Jedlicková K; Pikalová Z; Sulovská I
    Vnitr Lek; 2001 Sep; 47 Suppl 1():8-14. PubMed ID: 11693065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cytogenetic abnormalities as prognostic factors in acute myeloid leukemia].
    Chauffaille ML; Yamamoto M; Moncau JE; Braga GW; Souto EX; Kerbauy J
    Rev Assoc Med Bras (1992); 1996; 42(4):200-4. PubMed ID: 9181734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
    Bloomfield CD; Lawrence D; Byrd JC; Carroll A; Pettenati MJ; Tantravahi R; Patil SR; Davey FR; Berg DT; Schiffer CA; Arthur DC; Mayer RJ
    Cancer Res; 1998 Sep; 58(18):4173-9. PubMed ID: 9751631
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytogenetic profile of a large cohort of Tunisian de novo acute myeloid leukemia.
    Gmidène A; Sennana H; Wahchi I; Youssef YB; Jeddi R; Elloumi M; Saad A
    Hematology; 2012 Jan; 17(1):9-14. PubMed ID: 22549442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of specific cytogenetic aberrations with mdr1 gene expression in adult myeloid leukemia and its implication in treatment outcome.
    Schaich M; Harbich-Brutscher E; Pascheberg U; Mohr B; Soucek S; Ehninger G; Illmer T
    Haematologica; 2002 May; 87(5):455-64. PubMed ID: 12010657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party.
    Chessells JM; Harrison CJ; Kempski H; Webb DK; Wheatley K; Hann IM; Stevens RF; Harrison G; Gibson BE;
    Leukemia; 2002 May; 16(5):776-84. PubMed ID: 11986937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia. A single center study.
    Mitterbauer M; Laczika K; Novak M; Mitterbauer G; Hilgarth B; Pirc-Danoewinata H; Schwarzinger I; Haas OA; Fonatsch C; Lechner K; Jaeger U
    Am J Clin Pathol; 2000 Mar; 113(3):406-10. PubMed ID: 10705822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytobiological and clinicobiological features of AML with 11q23 chromosome abnormalities.
    Liu LB; Liu L; Wang XB; Xiao J; Zou P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):932-6. PubMed ID: 16403253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical significance of cytogenetics in acute myeloid leukemia.
    Mrózek K; Heinonen K; de la Chapelle A; Bloomfield CD
    Semin Oncol; 1997 Feb; 24(1):17-31. PubMed ID: 9045301
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Utility of interphase FISH to stratify patients into cytogenetic risk categories at diagnosis of AML in an Eastern Cooperative Oncology Group (ECOG) clinical trial (E1900).
    Vance GH; Kim H; Hicks GA; Cherry AM; Higgins R; Hulshizer RL; Tallman MS; Fernandez HF; Dewald GW
    Leuk Res; 2007 May; 31(5):605-9. PubMed ID: 16996130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.